FNDC5 and diabetes mellitus: This heterogeneity likely arises from multiple sources, including differences in irisin detection methods (e.g., varying ELISA kits), biospecimen types (serum vs. plasma), population characteristics (e.g., geographic region, ethnicity, diabetes duration), and diagnostic criteria for diabetic nephropathy.